Traders Purchase Large Volume of Call Options on Enovix (NASDAQ:ENVX)

Enovix Corporation (NASDAQ:ENVX) was the target of unusually large options trading on Thursday. Stock investors acquired 17,357 call options on the company. This represents an increase of 24% compared to the average daily volume of 13,989 call options.

Institutional Investors Weigh In On Enovix

Several hedge funds and other institutional investors have recently modified their holdings of ENVX. NewEdge Advisors LLC increased its holdings in Enovix by 4.7% in the 1st quarter. NewEdge Advisors LLC now owns 41,460 shares of the company’s stock worth $215,000 after acquiring an additional 1,853 shares during the last quarter. Wealthfront Advisers LLC raised its stake in Enovix by 27.8% in the 1st quarter. Wealthfront Advisers LLC now owns 13,800 shares of the company’s stock valued at $71,000 after acquiring an additional 3,001 shares during the period. Harbor Investment Advisory LLC raised its stake in Enovix by 32.5% in the 2nd quarter. Harbor Investment Advisory LLC now owns 18,740 shares of the company’s stock valued at $114,000 after acquiring an additional 4,600 shares during the period. Refined Wealth Management lifted its holdings in Enovix by 0.7% during the third quarter. Refined Wealth Management now owns 850,768 shares of the company’s stock valued at $2,467,000 after purchasing an additional 5,918 shares during the last quarter. Finally, The Manufacturers Life Insurance Company lifted its holdings in Enovix by 8.9% during the first quarter. The Manufacturers Life Insurance Company now owns 86,474 shares of the company’s stock valued at $448,000 after purchasing an additional 7,075 shares during the last quarter. Institutional investors own 50.92% of the company’s stock.

Analyst Ratings Changes

Several equities analysts have issued reports on the company. Oppenheimer lowered Enovix from an “outperform” rating to a “market perform” rating in a research note on Friday. Northland Securities set a $4.00 price objective on shares of Enovix in a research report on Tuesday, October 13th. Canaccord Genuity Group lowered their price objective on shares of Enovix from $12.00 to $8.00 and set a “buy” rating for the company in a research note on Friday, August 14th. Loop Capital upgraded shares of Enovix to a “strong-buy” rating in a research note on Monday, August 17th. Finally, TD Cowen upgraded shares of Enovix to a “hold” rating in a research report on Monday, October 5th. One investment analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating, six have given a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat.com, Enovix currently has an average rating of “Hold” and an average price target of $7.80.

Enovix Price Performance

ENVX stock opened at $1.60 on Friday. The company has a debt-to-equity ratio of 2.46, a current ratio of 9.71 and a quick ratio of 9.37. The company’s 50-day moving average is $2.23 and its 200-day moving average is $3.93. The stock has a market capitalization of $351.12 million, a PE ratio of -2.19 and a beta of 2.34. Enovix has a 1 year low of $1.53 and a 1 year high of $9.19.

Enovix (NASDAQ:ENVX) last issued its earnings results on Friday, November 13th. The company reported ($0.15) EPS for the quarter, beating analysts’ consensus estimates of ($0.20) by $0.05. Enovix had a negative return on equity of 67.80% and a negative net margin of 406.54%. The business had revenue of $11.04 million during the quarter. Equities research analysts expect that Enovix will post -0.79 EPS for the current fiscal year.

Key Stories Impacting Enovix

Investors following ENVX have been watching these stories:

• Positive Sentiment: Third-quarter revenue rose 38% year over year to $11 million, and the reported loss per share was narrower than analysts expected. Enovix forecast $65 million–$85 million in FY2027 revenue, with a roughly $37 million backlog cited as support. Enovix Q3 results and outlook
• Negative Sentiment: Three firms cut their ratings: Oppenheimer moved to “market perform,” Craig Hallum to “hold,” and B. Riley to “neutral.” B. Riley also slashed its price target from $9 to $2, reflecting sharply weaker analyst expectations. B. Riley ratings
• Negative Sentiment: Law firms announced investigations into whether Enovix misled investors, including about the readiness of its AI-1 silicon-anode cells for phone qualification. The announcements followed a steep share-price decline and may add uncertainty, although they do not establish that securities laws were violated. Block & Leviton investigation announcement

Enovix Company Profile

Enovix Corporation develops lithium-ion batteries using a silicon-based anode and a proprietary three-dimensional cell architecture. Its design is intended to increase energy density while addressing safety and performance requirements in compact devices. The company’s batteries are designed for applications including smartphones, wearable devices, laptops, augmented- and virtual-reality products, and other portable electronics. Enovix also targets markets such as defense and industrial technology.